Lenalidomide Maintenance Therapy May Be Best Treatment for Newly Diagnosed Multiple Myeloma
A meta-analysis of 11 studies rated the efficacy of 8 maintenance therapies with lenalidomide in combination or as monotherapy for NDMM.
Diagnosis & Disease Information
VT Maintenance Improves PFS vs Thalidomide or Interferon in Myeloma
In this study, maintenance therapy with bortezomib plus thalidomide was compared with thalidomide alone or interferon alfa-2b alone in patients with newly diagnosed symptomatic multiple myeloma. Study findings demonstrate an impact on progression-free survival.
Longer Maintenance Therapy Duration May Improve Survival in Myeloma
A longer duration of lenalidomide maintenance therapy after autologous HSCT may improve progression-free and overall survival in patients with multiple myeloma.
Triplet Regimen Followed by Maintenance Active in Triple-negative Breast Cancer
A first-line triplet chemoimmunotherapy regimen comprised of paclitaxel, capecitabine, and bevacizumab followed by capecitabine and bevacizumab alone as maintenance therapy is highly active with a manageable safety profile in patients with triple-negative breast cancer.
- Loading...
Loading...
Loading... 
Loading...